Farther Finance Advisors, LLC

Position in SYK — Stryker Corp

CIK 1992825 SAN FRANCISCO, CA

Position in SYK

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$5,613,631

+$414,336 QoQ

Shares Held

17,084

+15.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $25,381,241 across 88 Medical Devices names. SYK ranks #2 (22.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	72,818	$7,476,224
2	SYK	Stryker Corp This page	17,084	$5,613,631
3	MDT	Medtronic plc	59,342	$5,141,984
4	BSX	Boston Scientific Corp	22,272	$1,397,568
5	EW	Edwards Lifesciences Corp	14,039	$1,124,243
6	STE	STERIS plc	3,208	$709,385
7	GEHC	GE HealthCare Technologies Inc.	9,046	$643,894
8	DXCM	Dexcom Inc	9,960	$625,488

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,613,631	17,084	+15.5%	Shares	Sole	2026-04-07
2025-12-31	$5,199,295	14,793	+52.0%	Shares	Sole	2026-01-23
2025-09-30	$3,598,737	9,735	+28.8%	Shares	Sole	2025-10-14
2025-06-30	$2,990,171	7,558	+11.2%	Shares	Sole	2025-07-11
2025-03-31	$2,530,927	6,799	+7.9%	Shares	Sole	2025-04-14
2024-12-31	$2,269,395	6,303	-15.1%	Shares	Sole	2025-02-10
2024-09-30	$2,683,078	7,427	-5.2%	Shares	Sole	2024-10-29
2024-06-30	$2,665,178	7,833	+61.4%	Shares	Sole	2024-07-31
2024-03-31	$1,737,100	4,854	-27.4%	Shares	Sole	2024-05-14
2023-12-31	$2,002,189	6,686	+215.7%	Shares	Sole	2024-02-15
2023-09-30	$578,785	2,118	+100.4%	Shares	Sole	2023-11-14
2023-06-30	$322,480	1,057	+55.7%	Shares	Sole	2024-05-14
2023-03-31	$193,834	679	-16.8%	Shares	Sole	2024-05-14
2022-12-31	$199,503	816	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.